Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: The Memphis experience

International Journal of Radiation Oncology Biology Physics

Volumn 38, Issue 2, 1997, Pages 263-271

  Robbins, K Thomas ^a,c   Kumar, Parvesh ^a   Regine, William F ^a   Wong, Frank S H ^a   Weir III, Alva B ^b   Flick, Pamela ^a   Kun, Larry E ^a   Palmer, Robert ^b   Murry, Thomas ^a   Fontanesi, James ^a   Ferguson, Robert ^b   Thomas, Randall ^a   Hartsell, William ^a   Paig, Camilo U ^a   Salazar, George ^a   Norfleet, Linda ^a   Hanchett, Catherine B ^a   Harrington, Vanessa ^a   Niell, H Barry ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b BAPTIST MEMORIAL HOSPITAL   (United States)

^c NONE   (United States)

Author keywords

Concomitant radiation therapy; Head and neck cancer; Targeted supradose cisplatin

Indexed keywords

CISPLATIN; SODIUM THIOSULFATE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; CANCER RADIOTHERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG MEGADOSE; FEMALE; GASTROINTESTINAL TOXICITY; HEAD AND NECK CARCINOMA; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTICENTER STUDY; NEUROTOXICITY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION INJURY; SQUAMOUS CELL CARCINOMA; VASCULAR DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEASIBILITY STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; RADIATION-SENSITIZING AGENTS;

EID: 0030746369     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00092-8     Document Type: Article

References (37)

1. Al-Sarraf, M.; Pajak, T. F.; Marcial, V.; Mowry, P.; Cooper, X.; Stetz, J.; Ensley, J. F.; Velez-Garcia. E. Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck, a RTOG study. Cancer 59:259-265; 1987.
2. Andrews, P. A.; Murphy, M. P.; Howell, S. B. Characterization of cisplatin-resistant COLO 316 human ovarian carcinoma cells. Eur. J. Cancer Clin. Oncol. 25:619-662; 1989.
3. Andrews, P. A.; Jones, J. A.; Varkl, N. M.; Howell, S. B. Rapid emergence of acquired cis-diamminadichloroplatinum (II) resistance in an in vivo model or human ovarian carcinoma. Cancer Commun. 2:93-100; 1990.
4. Bachaud, J. M.; David, J. M.; Boussin, G. Combined post-operative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: Preliminary report of a randomized trial. Int. Radiat. Oncol. Biol. Phys. 20:243-246; 1991.
5. Cheung, D. K.; Regan, J.; Savin, M.; Gibberman, V.; Scessner, W. A pilot study of intraarterial chemotherapy with cisplatin in locally advanced head and neck cancers. Cancer 61:903-906; 1988.
6. Claudio, F.; Rotondi, M.; Bonassi, S.; Cacacer, F.; Comella, G.; Coucourde, F.; Claudia, P. P.; Bevilacqua, A. M.; Ionna, F.; Toma, S. Factors affecting response and survival in advanced head and neck cancers treated with intraarterial chemotherapy. Regul. Cancer 4:180-187; 1992.
7. The Department of VA Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N. Engl. J. Med. 324:1685; 1991.
8. Eckman, W. W.; Patlak, C. S.; Fenstermacher, J. D. A critical evaluation of the principles governing the advantages of intra-arterial infusions. J. Pharmacokinet. Biopharmacol. 2:257-285; 1974.
9. Forastlero, A. A.; Baker, S. R.; Wheeler, R.; Medve, B. R. Intra-arterial cisplatin and FUDR in advanced malignancies confined to the head and neck. J. Clin. Oncol. 5:1601-1606; 1987.
10. Frustaci, S.; Barzan, L.; Carusco, G.; Ghirado, R.; Foladore, S.; Carbone, A.; Conoretto, R.; Serafini, I.; Monfardini, S. Induction intraarterial cisplatin and bleomycin in head and neck cancer. Head Neck 13:291-297; 1991.
11. Haselow, R. E.; Warshaw, M. G.; Oken, M. W.; et al. Radiation alone versus radiation with weekly low dose cisplatinum in unresectable cancer of the head and neck. In: Fee, W. E., Jr.; Goepfert, H.; Johns, M. E.; et al., eds. Head and neck cancer, vol. 2. Philadelphia, PA: B. C. Decker; 1989:279-281.
12. Head & Neck Contracts Program: Adjuvant Chemoradiation for advanced head and neck squamous cell carcinoma: Final report of the head and neck contracts program. Cancer 60:301-311; 1987.
13. Galmarini, F. C.; Yoel, H.; Abulaafia, J.; Nakasone, J.; Temperley, G. Intra-arterial cispiatinum in head and neck cancer - controlled clinical trial in phases I and II (abstr). Head Neck Surg. 257: 1981.
14. Howell, S. B.; Tastle, R. The effect of sodium thiosulfate on cis-dichlorodaimminedplatin (II) nephrotoxicity and antitumor activity in the L1210 leukemia. Cancer Treat. Rep. 64:611-615; 1980.
15. Howell, S. B.; Pfeifle, C. E.; Wung, W. E.; Ohshen, R. A.; Lucas, W. E.; Yon, J. L.; Green, M. Intraperitoneal cisplatin with systemic thiosulfate protection. Ann. Intern. Med. 97:845-851; 1982.
16. Howell, S. B. Pharmacokinetic principles of regional chemotherapy. Contr. Oncol. 29:1-8; 1988.
17. Inoue, K.; Mukaiyama, T.; Mitsui, I.; Ogawa, M. In vitro evaluation of anticancer drugs in relation to development of drug resistance in the human tumor cologenic assay. Cancer Chemother. Pharmacol. 15:208-213; 1985.
18. Laramore, S.; El-Sarraf, C. B.; Haselow, E. T. J.; Wheeler, R. O.; Jacobs, J. R.; Schuller, D. E.; Gahbauer, R. A.; Schwade, J. G.; Campbell, B. H. Int. J. Radiat. Oncol. Biol. Phys. 23:705-713; xxxx.
19. Lee, Y. Y.; Dimery, I.; Van Tassel, P.; De Pena, C.; Blacklock, B.; Goepfert, H. Superselective intra-arterial chemotherapy of advanced paranasal sinus tumors. Arch Otol. HNS115:503-511; 1989.
20. Marcial, P.; Pajek, V.; Thomas, F. Radiation therapy alone or in combination with surgery in head & neck cancer. Cancer 55:2259-2265; 1985.
21. Marcial, V. A.; Pajak, T. F.; Mohiuddin, M.; Cooper, J. S.; Al-Arraf, M.; Mowry, P. A.; Curran, W.; Crissman, J.; Rodrigruez, M.; Velez-Garcia, E. Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Cancer 66:1861-1868; 1990.
22. Merlano, M.; Grimaldi, A.; Benasso, M.; Bacigalupo, A.; Toma, S.; Scarpati, D.; Corvo, R.; Santelli, A.; Garaventa, G.; Rosso, R. Alternating cisplatin 5-fluorouracil and radiotherapy in head and neck cancer. Am. J. Clin. Oncol. (CCT) 11:538-542; 1988.
23. Molinari, R. Preliminary intraarterial chemotherapy in cancer of the oral cavity: Long-term results of combined treatments with surgery and radiotherapy. In: Cretian, P. B.; Johns, M. E.; Shedd, D. P., et al., eds. Head and neck cancer. Philadelphia, PA: Decker; 1985:456-461.
24. Mortimer, J. E.; Taylor, E.; Schulmans, X.; Cummings, C.; Weymuller, E.; Laramore, G. Feasibility and efficacy of weekly intraarterial cisplatin in locally advanced (III and IV) head and neck cancers. J. Clin. Oncol. 6:969-975; 1988.
25. Murthy, A. K.; Taylor, S. G., IV; Showel, J.; Caldarelli, D. D.; Hutchinson, J. C., Jr., Holinger, L. D.; Witt, T. R.; Hoover, S. Int. J. Radiat. Oncol. Biol. Phys. 13:1807-1813; 1987.
26. Robbins, K. T.; Storniolo, A. M.; Kerber, C.; Seagren, S.; Berson, A.; Howell, S. B. Rapid supraselective high dose cisplatin infusion for advanced head and neck malignancies. Head Neck 14:364-371; 1992.
27. Robbins, K. T.; Storniolo, A. M.; Kerber, C.; Vicario, D.; Seagren, S.; Shea, M.; Hanchett, C.; Los, G.; Howell, S. B. Phase I study of highly selective supradose cisplatin Infusions for advanced head and neck Cancer. J. Clin. Oncol.; 1994.
28. Robbins, K. T.; Vicario, D.; Seagren, S.; Weisman, R.; Pelliteri, P.; Kerber, C.; Los, G.; Howell, S. B. A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer. Am. J. Surg.; 1994.
29. Schuller, D. E.; Wilson, H. E.; Smith, R. E.; Batley, F.; James, A. D. Preoperative reductive chemotherapy for locally advanced carcinoma of the oral cavity, oropharynx, and hypopharynx. Cancer 51:15-19; 1983.
30. Slotman, G. J.; Cummings, F. J.; Glicksman, A. R.; Doolittle, C. L.; Leone, L. A. Preoperative simultaneously administered cisplatinum plus radiation therapy for advanced squamous cell carcinoma of the head and neck. Head Neck Surg. xx:L59-L164; 1986.
31. Taylor, S. G., IV; Murthy, A. K.; Caldarelli, D. D.; Showel, J. L.; Kiel, K.; Griem, K. L.; Mittal, B. B.; Kies, M.; Hutchinson, J. C., Jr.; Holinger, L. D.; Campanella, R.; Witt, T. R.; Hoover, S. Combined simultaneous cisplatin/fluorouracil chemotherapy and split course radiation in head and neck cancer. J. Clin. Oncol. 7:846-856; 1989.
32. Teicher, B. A.; Holden, S. A.; Kelley, M. J.; Shea, T. C.; Cucchi, C. A.; Rosowsky, A.; Henner, W. D.; Frei, E., III. Characterization of a human squamous cell carcinoma cell line resistant to Platinum platinum (II). Cancer Res. 47:388-393; 1987.
33. Vokes, E. E.; Weichselbaum, R. R. Concomitant chemoradiotherapy: Rationale and clinical experience in patients with solid tumors. J. Clin. Oncol. 8:911-934; 1990.
34. Wendt, T. G.; Hartenstein, R. C.; Wustrow, T. P. U.; Lissner, X. Cisplatin, fluorouracil with Leucovorin calcium management of locally advanced head and neck cancer: A phase II study. J. Clin. Oncol. 7:471-476; 1989.
35. Wheeler, R. H.; Ziessman, H. A.; Medvec, B. R., et al. Tumor blood flow and systemic shunting in patients receiving intraarterial chemotherapy for head and neck cancer. Cancer Res. 46:4200-4204; 1986.
36. Wingo, P. A.; Tong, T.; Bolden, S. Cancer Stat. 1995. CA. A Cancer Journal For Clinicians. 45:8-30; 1995.
37. Wolpert, S. W.; Kwan, E. S.; Heros, D.; Kasdon, D. L.; Hedges, T. R. Selective delivery of chemotherapeutic agents with a new catheter system. Radiology 166:547-549; 1988.